day 1 agenda

World Congress on Vaccines
July 10-11, 2025 @ Vienna, Austria
Day-1 (July 10, 2025)
08:30-09:30                                            Registrations 
09:45-10:15                            Welcome Remarks by Moderator
Keynote Talks
Liang Zhou, University of Florida, USA 09:45-10:15 The role of Innate Lymphoid Cells in Mucosal Infection
Nisha J Garg, Washington University, USA 10:15-10:45 Subunit nanovaccine elicited T cell functional activation controls Trypanosoma cruzi mediated maternal and placental tissue damage and improves pregnancy outcomes in mice
Monica Lahra, NSW Health Pathology, Australia 10:45-11:15 Multidrug resistant N. gonorrhoeae
Group Photo & Refreshment Break (11:15-11:35)
Technical Session-I 
Session Chairs: TBA
Jooeun Bae, Harvard Medical School, USA 11:35-11:55 Combinational Immunotherapy with Multi-antigen targeting Cancer Vaccine
Júlia Vergara-Alert, Institute of Agrifood Research and Technology, Spain 11:55-12:15 Discovery of an inhibitor ligand of IFNAR1: a new mechanism for viruses to escape from cellular innate immunity
Lina Souan, King Hussein Cancer Center, Jordan 12:15-12:35 Effectiveness and Duration of Anti-RBD SARS-CoV-2 IgG Response Across Vaccines: Implications for Vaccine Strategies
Xiufen Zheng, Western University, Canada 12:35-12:55 Potentials and challenges of circular RNA as a therapy/vaccine  in treating diseases 
Lunch Break @ Restaurant (12:55-14:00)
Technical Session-II
Session Chairs: TBA
Shin, Yeun-Kyung, Animal and Plant Quarantine Agency, South Korea 14:00-14:20 Propagation of porcine reproductive and respiratory syndrome virus increases in
PRRSV-susceptible porcine kidney cells modifying LGP2 and RIG-I
I Y Saleem, Liverpool John Moores University, UK 14:20-14:40 Inhalable Nanovaccine Targeting Pneumococcal Proteins for Lung Protection
Ximeng Han, Jenner Institute, University of Oxford, UK 14:40-15:00 Preclinical Development of an Enhanced-Immunogenicity Pfs230-Pfs25 Malaria Transmission-Blocking Vaccine
Baek Kim, Vernagen LLC, USA 15:00-15:20 Immunogenicity and protective efficacy of Respiratory Syncytial Virus mRNA vaccine encoding the F protein of both RSV subtypes A and B in a BALB/c mouse model
João Luis Garcia, Londrina State University, Spain 15:20-15:40 Vaccines against Toxoplasma gondii: the past, the present and the future
Yoon-Hee Lee, Animal and Plant Quarantine Agency, South Korea 15:40-16:00 The appication of Nano-Luciferase based biosensor for the detection of FMDV(Foot and Mouth Disease Virus) type Asia1
Refreshment Break (16:00-16:20)
Lorena Carmona Rodriguez, Stablepharma Ltd, Spain 16:20-16:40 TBA
  16:40-17:00 Slot Available
Pannel Discussions

day 2 agenda

Day-2 (July 11, 2025) 
Keynote Talks
Tian Wang,University of Texas Medical Branch, USA 09:30-10:00 Development of safe and efficacious vaccines against emerging arboviruses
Jerald Sadoff, Centivax Inc, USA 10:00-10:30 Universal vaccines against influenza and other pathogens
Taijiao Jiang, Guangzhou Medical University, China 10:30-11:00 Modeling influenza antigenic evolution for vaccination by PREDAC
Refreshment Break (11:00-11:20)
Technical Session-III
Session Chairs: TBA
Maja Mockenhaupt, University of Freiburg, Germany 11:20-11:40 Infections as possible trigger of epidermal necrolysis
Ximeng Han, University of Oxford, United Kingdom 11:40-12:00 Preclinical Development of an Enhanced-Immunogenicity Pfs230-Pfs25 Malaria Transmission-Blocking Vaccine
Jerina Jaho, University "Ismail Qemali" Vlore, Albania 12:00-12:20 Patients with HIV and Hepatitis B co-infection present special requirements for their management
Pooja Goel, The Lyndhurst Surgery, UK 12:20-12:40 Barriers to the Flu Vaccination: Patients’ Perspective within a London GP
Hamsa Taher Tayeb, King Faisal Specialist Hospital & Research Center, Saudi Arabia 12:40-13:00 Implementation of Next Generation Sequencing (NGS) as a Diagnostic Tool in Infectious Diseases
Lunch Break @ Restaurant (13:00-14:00)
Poster Presentations(14:00-15:00)
Technical Session-IV
Session Chairs: TBA
Ying Liao, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, China 15:00-15:20 Coronavirus Nucleocapsid Protein Enhances p-PKCα Binding to RACK1: Implications for Inhibition of Nucleocytoplasmic Trafficking and Suppression of the Innate Immune Response
Polona Kogovšek, National institute of biology, Slovenia 15:20-15:40 TBA
Szu-Hao Kung, National Yang Ming Chiao Tung University, Taiwan 15:40-16:00 Development of ionophore antibiotics as antiviral agents against enteroviruses and coronaviruses
Refreshment Break (16:00-16:20)
Filomena Fiorito, University of Naples Federico II, Italy 16:20-16:40 TBA
  16:40-17:00 Slot Available
Luca Del Sorbo, University of Naples Federico II, Italy 17:00-17:20 TBA
  17:20-17:40 Slot Available
Award Ceremony 
Day 2 Concludes
NOTE: This is Tentative program and subject to change
For more information, Contact @ ryan_cooper@vaccine-congress.org

Download